C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15 | – | 1,850 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 1,850 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $11 | -99.9% | 1,850 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $16,000 | +14.3% | 1,850 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $14,000 | +75.0% | 1,850 | +428.6% | 0.00% | +100.0% |
| Q1 2022 | $8,000 | -27.3% | 350 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $11,000 | -8.3% | 350 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $12,000 | -20.0% | 350 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $15,000 | +15.4% | 350 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $13,000 | – | 350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $15,939,000 | 8.67% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $54,406,000 | 3.42% |
| Darwin Global Management, Ltd. | 228,595 | $7,573,000 | 2.11% |
| Asymmetry Capital Management, L.P. | 139,343 | $4,616,000 | 2.10% |
| Cormorant Asset Management, LP | 2,490,065 | $80,021,000 | 1.90% |
| Logos Global Management LP | 477,928 | $15,834,000 | 1.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 443,824 | $14,601,000 | 1.30% |
| Soleus Capital Management, L.P. | 268,548 | $8,897,000 | 1.17% |
| P.A.W. CAPITAL CORP | 40,000 | $1,325,000 | 1.17% |
| RTW INVESTMENTS, LP | 2,149,228 | $68,679,000 | 1.15% |